Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupuncture for Treatment of Peripheral Neuropathy Induced by Neoadjuvant or Adjuvant Paclitaxel in Early Stage Breast Cancer: a Sham Controlled, Randomized Study

NCT04461977 is registered in ClinicalTrials.gov with Instituto Brasileiro de Controle do Cancer as lead sponsor.

NCT NCT04461977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04461977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupuncture for Treatment of Peripheral Neuropathy Induced by Neoadjuvant or Adjuvant Paclitaxel in Early Stage Breast Cancer: a Sham Controlled, Randomized Study
Lead sponsor
Instituto Brasileiro de Controle do Cancer
Phase
Not applicable
Overall status
Completed
Start date
January 30, 2020
Completion date
March 26, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy due to chemotherapy